Drugs / DKP21102_B
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT05809687 | Jan 2025 → Dec 2026 | hyperlipidemia | Dongkwang Pharm. Co., Ltd. | Withdrawn | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DKP21102_B | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05809687 ↗ |